AFP examines expansion of Indian drug companies in South Africa

Agence France-Presse examines how Indian drug companies have infiltrated the South African market over the last few years in an effort to have a broader reach in Africa. India's pharmaceutical industry is now the second largest in the world by volume, according to AFP.

"Unlike most multinational companies, India's 'big three' pharmaceuticals - Ranbaxy, Cipla and Dr. Reddy's - have carefully cultivated their local credentials by bringing South Africans into the top corporate echelons. ... Cheap generic drugs have been the catalysts of that growth, and Africa has been a key market, buying 14 percent of India's $8-billion pharmaceutical exports in 2009," the news service writes. "Ranbaxy and Cipla have also won fans by slashing the price of anti-AIDS drugs ... Providing discount generics has been big business and helped the Indian industry displace its Western rivals," the article notes (Berger, 5/22).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy